The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population

被引:68
|
作者
Osorio, A
Rodríguez-López, R
Díez, O
de la Hoya, M
Martínez, JI
Vega, A
Esteban-Cardeñosa, E
Alonso, C
Caldés, T
Benítez, J
机构
[1] Spanish Natl Canc Ctr, Dept Human Genet, Madrid 28029, Spain
[2] Fac Med, Dept Chem & Mol Biol, Valladolid, Spain
[3] Conxo Hosp, Dept Mol Med, Santiago De Compostela, Spain
[4] FVIB, Inst Invest Citol, Valencia, Spain
[5] San Carlos Univ Hosp, Mol Oncol Lab, Madrid, Spain
[6] Sant Pau Hosp, Serv Genet, Barcelona, Spain
[7] Sant Pau Hosp, Serv Oncol, Barcelona, Spain
关键词
CHEK2; low-penetrance variant; familial breast cancer; Spanish population;
D O I
10.1002/ijc.11414
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Searching for low-penetrance genes involved in breast cancer susceptibility has been a field of interest in the last few years. Recently, the CHEK 2 gene, involved in DNA damage and replication checkpoints, has been pointed out as a good candidate; moreover, a specific variant in this gene, 1100delC, has been found to increase breast cancer susceptibility among familial breast cancer cases not attributable to mutations in BRCA1 or BRCA2 genes. In our present study, we evaluated the role of the 1100delC variant as a susceptibility allele in breast cancer in the Spanish population. However, our results suggest that this variant is absent or very infrequent in our population, making its screening irrelevant from the practical point of view. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:54 / 56
页数:3
相关论文
共 50 条
  • [21] Excess breast cancer risk in first degree relatives of CHEK2*1100delC positive familial breast cancer cases
    Adank, Muriel A.
    Verhoef, Senno
    Oldenburg, Rogier A.
    Schmidt, Marjanka K.
    Hooning, Maartje J.
    Martens, John W. M.
    Broeks, Annegien
    Rookus, Matti
    Waisfisz, Quinten
    Witte, Birgit I.
    Jonker, Marianne A.
    Meijers-Heijboer, Hanne
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (08) : 1993 - 1999
  • [22] CHEK2 1100delC mutation is frequent among Russian breast cancer patients
    Chekmariova, Elena V.
    Sokolenko, Anna P.
    Buslov, Konstantin G.
    Iyevleva, Aglaya G.
    Ulibina, Yulia M.
    Rozanov, Maxim E.
    Mitiushkina, Natalia V.
    Togo, Alexandr V.
    Matsko, Dmitry E.
    Voskresenskiy, Dmitry A.
    Chagunava, Oleg L.
    Devilee, Peter
    Cornelisse, Cees
    Semiglazov, Vladimir F.
    Imyanitov, Evgeny N.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 (01) : 99 - 102
  • [23] The CHEK2*1100delC mutation predisposes for early onset breast cancer in breast cancer families.
    Van Binst, T
    Goelen, G
    Sermijn, E
    Van Hassel, G
    De Neef, K
    Bonduelle, M
    Fontaine, C
    Teugels, E
    De Greve, JJ
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S151 - S151
  • [24] CHEK2 1100delC mutation is frequent among Russian breast cancer patients
    Elena V. Chekmariova
    Anna P. Sokolenko
    Konstantin G. Buslov
    Aglaya G. Iyevleva
    Yulia M. Ulibina
    Maxim E. Rozanov
    Natalia V. Mitiushkina
    Alexandr V. Togo
    Dmitry E. Matsko
    Dmitry A. Voskresenskiy
    Oleg L. Chagunava
    Peter Devilee
    Cees Cornelisse
    Vladimir F. Semiglazov
    Evgeny N. Imyanitov
    Breast Cancer Research and Treatment, 2006, 100 : 99 - 102
  • [25] Colorectal cancer and the CHEK2 1100delC mutation
    de Jong, MM
    Nolte, IM
    Meerman, GJT
    van der Graaf, WTA
    Mulder, MJ
    van der Steege, G
    Bruinenberg, M
    Schaapveld, M
    Niessen, RC
    Berends, MJW
    Sijmons, RH
    Hofstra, RMW
    de Vries, EGE
    Kleibeuker, JH
    GENES CHROMOSOMES & CANCER, 2005, 43 (04): : 377 - 382
  • [26] Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy
    M Kriege
    A Hollestelle
    A Jager
    P E A Huijts
    E M Berns
    A M Sieuwerts
    M E Meijer-van Gelder
    J M Collée
    P Devilee
    M J Hooning
    J W M Martens
    C Seynaeve
    British Journal of Cancer, 2014, 111 : 1004 - 1013
  • [27] CHEK2*1100delC homozygosity in the Netherlands—prevalence and risk of breast and lung cancer
    Petra EA Huijts
    Antoinette Hollestelle
    Brunilda Balliu
    Jeanine J Houwing-Duistermaat
    Caro M Meijers
    Jannet C Blom
    Bahar Ozturk
    Elly MM Krol-Warmerdam
    Juul Wijnen
    Els MJJ Berns
    John WM Martens
    Caroline Seynaeve
    Lambertus A Kiemeney
    Henricus F van der Heijden
    Rob AEM Tollenaar
    Peter Devilee
    Christi J van Asperen
    European Journal of Human Genetics, 2014, 22 : 46 - 51
  • [28] Analysis of CHEK2 1100delC in North American breast cancer families and population based breast cancer series.
    Walsh, T
    Young, TL
    Snook, S
    Newman, B
    Milikan, B
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 181 - 181
  • [29] CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women
    Adank, Muriel A.
    Jonker, Marianne A.
    Kluijt, Irma
    van Mil, Saskia E.
    Oldenburg, Rogier A.
    Mooi, Wolter J.
    Hogervorst, Frans B. L.
    van den Ouweland, Ans M. W.
    Gille, Johan J. P.
    Schmidt, Marjanka K.
    van der Vaart, Aad W.
    Meijers-Heijboer, Hanne
    Waisfisz, Quinten
    JOURNAL OF MEDICAL GENETICS, 2011, 48 (12) : 860 - 863
  • [30] Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy
    Kriege, M.
    Hollestelle, A.
    Jager, A.
    Huijts, P. E. A.
    Berns, E. M.
    Sieuwerts, A. M.
    Meijer-van Gelder, M. E.
    Collee, J. M.
    Devilee, P.
    Hooning, M. J.
    Martens, J. W. M.
    Seynaeve, C.
    BRITISH JOURNAL OF CANCER, 2014, 111 (05) : 1004 - 1013